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4Potentially Debilitating Effects
of Spaceflight Environment
• Bone Demineralization –
Osteoporosis
• Impaired Fracture Healing –
Non-Union
• Renal Stone Formation & 
Soft Tissue Calcification
• Orthostatic Intolerance (on 
return to gravity)
• Cardiac Arrhythmias
• Dehydration (on return to 
gravity)
• Decreased Aerobic Capacity
• Impaired Coordination
• Muscle Atrophy (Loss of 
Strength)
• Radiation Sickness
• Increased Cancer Risk
• Impaired Immune Function
• Behavioral Changes & 
Performance Decrements
• Altitude Decompression 
Sickness during EVA
5Research Venues
Flight Experiments
• long-duration space missions
• short-duration space missions
• parabolic trajectory aircraft 
Ground-based analog experiments 
• bed-rest (unloading of bones,muscles)
• Antarctica (isolation)
• NEEMO (isolation + confinement)
• Houghton-Mars (exploration, space 
medicine)
6Ways in which the Biostatistics Laboratory 
participates in the research process:
Design of experiments
• numbers of subjects
• how often measurements are made
Extracting information from experiment data
• develop or suggest data analysis procedures
• perform data analysis
Reporting results
• presentations
• assist with manuscript preparation for publication
7•extremely limited human subject pool
•support of NASA operations must be maintained
Constraints
8Dependent Measures
(examples)
• Clinical
ECG, bone density, muscle strength, urinalysis, 
blood, standard neuro, eye exams, VO2 max, 
HR
• Specialized
locomotion performance, nutritional markers, tilt 
test time, balance control, viral reactivation, 
cytokine production, buckling ratio, subjective 
sleepiness or discomfort scores
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•effective display of data
•longitudinal data (pre, in , post-flight)
•high variability between subjects
•highly unbalanced design (dictated by operations)
•multivariate measurements
•rich variety of distributions
skewed
limited range
time-to-event (“survival”)
discrete
zero-inflated
•multiple imputation
•models for simulation
•sample size / power estimation
•model selection  - multiple testing
Statistical challenges
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14Is the new CM any better than the old?
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Typical approach:
Judge effectiveness by difference in means.
Alternative approach:
Judge effectiveness by difference in percent of 
population protected against a big loss.
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Typical approach:
Judge effectiveness by difference in means.
Alternative approach:
•Estimation with uncertainty interval
How?
Ex.  0.020 ±0.008
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Typical approach:
Judge effectiveness by difference in means.
Alternative approach:
•Estimation with uncertainty interval
How?
•Statistical inference
“P-value”
Ex.  0.020 ±0.008
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effect of CM on proportion of population protected
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effect of CM on proportion of population protected
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Typical approach:
Alternative approach:
•Estimation with uncertainty interval
How?
•Statistical inference
Ex.  63%  (33%, 78%)
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Statistical Inference
Calculate something from the data (a “statistic” – call 
it  “T”) that gets larger as the observed effect of the 
new CM relative to the old CM increases.
data T
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Imagine the experiment being repeated many times, 
null 
experiments T1, T2, T3,..,T1000,...etc.
For each of these hypothetical experiments, imagine 
that T is recalculated.
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Statistical Inference
Calculate something from the data (a “statistic” – call 
it  “T”) that gets larger as the observed effect of the 
new CM relative to the old CM increases.
data T
Imagine the experiment being repeated many times, 
null 
experiments T1, T2, T3,..,T1000,...etc.
How likely is it that a “T” for one of these 
hypothetical null experiments would be greater than 
the value of T we calculated from the real data?
For each of these hypothetical experiments, imagine 
that T is recalculated.
P-value:
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Examples of Projects, Data
•environmental physiology
•behavioral health and performance
•neurological
•bone
•radiation
•cardiovascular
• Spacesuit is a closed life-support 
system.
• Consumables are used up in 
proportion to how hard an 
astronaut is working (met rate). 
• To predict how much longer an 
astronaut can safely continue an 
EVA, need to monitor his/her 
met rate (BTU/h).
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Monitoring Metabolic Rate during EVA
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Monitoring Metabolic Rate during EVA
O2
CO2
LCG
HR
•Data:
•4 disparate sensors – O2, CO2, HR, LCG
•each provides an estimate of met rate
•all estimates have errors 
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Monitoring Metabolic Rate during EVA
O2
CO2
LCG
HR
Problem:
How should one combine the 
individual met-rate estimates to obtain 
the most reliable single estimate?
•4 disparate sensors – O2, CO2, HR, LCG
•each provides an estimate of met rate
•all estimates have errors 
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What the data looks like?
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Our “Best Estimate”
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•thermal/gas-exchange  models
Techniques used
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•thermal/gas-exchange  models
•factor analysis
Techniques used
factor analysis model
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•thermal/gas-exchange  models
•factor analysis
•accuracy assessment using autoregressive error model
Techniques used
38
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•environmental physiology
•behavioral health and performance
•neurological
•bone 
•radiation
•exercise
Examples of Projects, Data
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Compare two cognitive tests that are designed to  show 
degraded performance with increasing sleepiness
Subjects take promethazine (PMZ).
At each of 12 timepoints:
•measure PMZ concentration in blood
•obtain subjective report of sleepiness (1-9 scale)
•record cognitive test performance - Test1, Test 2
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Compare two cognitive tests that are designed to  show 
degraded performance with increasing sleepiness
Subjects take promethazine (PMZ).
At each of 12 timepoints:
•measure PMZ concentration in blood
•obtain subjective report of sleepiness (1-9 scale)
•record cognitive test performance - Test1, Test 2
Which test is more sensitive to (true) sleepiness?
Sleepiness  
* Scores  1, 2Time  
Other
Time x 
PMZ
x 
PMZ  KSS
Latent Variable Model
44effect size
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•environmental physiology
•behavioral health and performance
•neurological
•bone 
•radiation
•exercise
Examples of Projects, Data
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Sensory Organization Test
(neurological)
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SOT Data 
•longitudinal design
•limited range (0 – 100)
•left-skewed distribution
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SOT Data 
•longitudinal design
•limited range (0 – 100)
•left-skewed distribution
•falls
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SOT Data 
longitudinal design
limited range (0 – 100)
left-skewed distribution
falls
Score of zero for falls is arbitrary.
Averaging in a zero for falls is not valid:
e.g. (60, fall ) is not the same as (30, 30).
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SOT Data 
longitudinal design
limited range (0 – 100)
left-skewed distribution
falls
Score of zero for falls is arbitrary.
Averaging in a zero for falls is not valid:
e.g. (60, fall ) is not the same as (30, 30).
Use latent variable model to represent unobserved 
balance control ability when there is a fall.
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•environmental physiology
• behavioral health and performance
•neurological
•bone
•radiation
•exercise
Examples of Projects, Data
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•environmental physiology
• behavioral health and performance
•neurological
•bone
•radiation
•exercise
Examples of Projects, Data
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Distinguishing characteristic:
AR1 regression coefficient (L1)
•Control group:
•L1 small => random (high frequency variation)
•Radiation group:
•L1 large => carryover (low frequency variation)
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Examples of Projects, Data
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Exercise data - (27 ISS astronauts)
Predictors:
x1 TVIS sessions per week
x2 TVIS avg session time
x1x2   TVIS min/week
x5 ln[ -(TVIS Load(lbs)) + 134.4 ]
x6 TVIS mph
x7 CEVIS avg session time
x8 CEVIS sessions per week
x7x8   CEVIS min/week
x13 RED avg squat load
x14 ln[ (RED avg DL load) -110.9 ]
68
Outcomes :
y1 Post-Pre Alk Phos
y2 Post-Pre NTELO
y3 Post-Pre Osteo
y4 Post-Pre BSAP
y5 Post-Pre Lspine BMD
y6 Post-Pre fneck BMD
y7 ln[ -(Post-Pre troc BMD)+.0183]
y8 ln[ -(Post-Pre whoebody BMD) + .0098]
y9 Post-Pre calc BMD
y10 Post-Pre pelvis BMD
Exercise data (cont.)
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Outcomes  (cont.)
y11 Post-Pre Back Ext
y12 Post-Pre Trunk Flex
y13 Post-Pre Ankle Consentric Plantar
y14 Post-Pre Ankle Consentric Dorsi
y15 Post-Pre Ankle Eccentric Plantar
y16 Post-Pre Ankle Eccentric Dorsi
y17 Post-Pre Hamstring Total Work
y18 Post-Pre Hamstring Strength
y19 Post-Pre Quads Total Work
y20 Post-Pre Quads Strength
y21 Post-Pre Estimated VO2 (raw)
y22 Post-Pre Weight-Adjusted Estimated VO2
Exercise data (cont.)
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Does exercise (in general) mitigate the adverse effects 
of space on these outcomes (bone markers, bone 
mineral density, muscle strength, fitness level (VO2) )?
If so, which aspects of exercise appear to have the most 
important effects?
Main Research Questions
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canonical correlation analysis
73
Data Matrix
74
Missing data
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